Nyxoah SA Cash on Hand 2021-2026 | NYXH

Nyxoah SA cash on hand from 2021 to 2026. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Nyxoah SA Annual Cash on Hand
(Millions of US $)
2025 $54
2024 $93
2023 $63
2022 $100
2021 $160
2020 $105
Nyxoah SA Quarterly Cash on Hand
(Millions of US $)
2026-06-30 $114
2026-03-31 $30
2025-12-31 $54
2025-09-30 $25
2025-06-30 $49
2025-03-31 $66
2024-12-31 $93
2024-09-30 $78
2024-06-30 $84
2024-03-31 $48
2023-12-31 $63
2023-09-30 $79
2023-06-30 $92
2023-03-31 $103
2022-12-31 $100
2022-09-30 $116
2022-06-30 $131
2022-03-31 $143
2021-06-30 $95
2021-03-31 $104
2020-12-31 $105
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.057B $0.011B
Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $42.130B 42.04
Tempus AI (TEM) United States $14.045B 0.00
10x Genomics (TXG) United States $9.980B 0.00
Hinge Health (HNGE) United States $7.658B 73.57
Hims & Hers Health (HIMS) United States $6.530B 0.00
Doximity (DOCS) United States $4.654B 28.69
Heartflow (HTFL) United States $4.413B 0.00
IRhythm Holdings (IRTC) United States $3.604B 237.67
Privia Health (PRVA) United States $2.536B 94.52
Clover Health Investments (CLOV) United States $2.369B 0.00
Inspire Medical Systems (INSP) United States $2.220B 33.82
Schrodinger (SDGR) United States $2.142B 0.00
Butterfly Network (BFLY) United States $2.098B 0.00
Omnicell (OMCL) United States $1.466B 20.93
Azenta (AZTA) United States $1.456B 79.14
Enovis (ENOV) United States $1.040B 5.39
Talkspace (TALK) United States $0.879B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.687B 0.00
Phreesia (PHR) United States $0.623B 33.47
Fulgent Genetics (FLGT) United States $0.597B 0.00
Veradigm (MDRX) United States $0.575B 0.00
Claritev (CTEV) United States $0.522B 0.00
Carlsmed (CARL) United States $0.425B 0.00
Evolent Health (EVH) United States $0.417B 0.00
Senseonics Holdings (SENS) United States $0.400B 0.00
CapsoVision (CV) United States $0.335B 0.00
Standard BioTools (LAB) United States $0.302B 0.00
American Well (AMWL) United States $0.228B 0.00
KORU Medical Systems (KRMD) United States $0.148B 0.00
Health Catalyst (HCAT) United States $0.135B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.131B 0.00
CareCloud (CCLD) United States $0.092B 6.78
Pulmonx (LUNG) United States $0.089B 0.00
Zepp Health (ZEPP) Netherlands $0.063B 0.00
Outset Medical (OM) United States $0.059B 0.00
P3 Health Partners (PIII) United States $0.056B 0.00
EUDA Health Holdings (EUDA) Singapore $0.053B 0.00
Precipio (PRPO) United States $0.047B 0.00
111 (YI) China $0.032B 0.00
MDxHealth SA (MDXH) Belgium $0.031B 0.00
Evaxion - (EVAX) Denmark $0.027B 0.00
HeartSciences (HSCS) United States $0.025B 0.00
HeartBeam (BEAT) United States $0.023B 0.00
Predictive Oncology (POAI) United States $0.020B 0.00
DataMeds AI (MEDS) United States $0.012B 0.00
Healthcare Triangle (HCTI) United States $0.012B 0.00
Lunai Bioworks (LNAI) United States $0.011B 0.00
Bullfrog AI Holdings (BFRG) United States $0.009B 0.00
ITonic Holdings (ITOC) China $0.005B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
PROFUSA (PFSA) United States $0.001B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.001B 0.00
Zhongchao (ZCMD) China $0.001B 0.00
TruBridge (TBRG) United States $0.000B 0.00